PDE2 promotes cardiac fibroblast to myofibroblast conversion and tissue stiffness by reducing cAMP, an effect that can be reversed by enhancing cGMP signaling.
No takes yet. Share an insight, caveat, or question.
PDE2 may represent an antifibrotic target via cAMP; hypothesis-generating for cGMP-based interventions in cardiac fibrosis.
Vettel et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: